Financial Health Assessment: ASSIGN-IT LIMITED

1. Financial Health Score: A

Explanation: ASSIGN-IT LIMITED is in exceptional financial shape. The company exhibits the financial equivalent of a resting heart rate of an elite athlete—highly liquid, carrying minimal debt, and demonstrating consistent long-term equity growth. There are no symptoms of financial distress; rather, the business shows robust stamina and a strong immune system against economic shocks.

2. Key Vital Signs

• Liquidity (Financial Blood Pressure): 3.35:1 Current Ratio
  • Interpretation: With Current Assets of £863,327 against Current Liabilities of £257,850, the company's financial blood pressure is very healthy. For every £1 of short-term obligations, the company has £3.35 in short-term assets, indicating absolutely no risk of a "cardiac arrest" (insolvency) in the near term.
• Cash Reserves (Financial Hydration): £698,738
  • Interpretation: Cash makes up roughly 81% of total assets. The business is exceptionally well-hydrated, holding more cash than its entire yearly trade debtors' ledger (£157,586). This provides massive operational security and flexibility.
• Debt Burden (Financial Cholesterol): £8,420 Long-term Liabilities
  • Interpretation: Long-term liabilities are virtually non-existent, dropping from £18,453 in 2023 to just £8,420 in 2024. The company's arteries are clear of harmful debt build-up, meaning future cash generation is not burdened by heavy repayment obligations.
• Equity Growth (Muscle Development): £601,509 Net Assets
  • Interpretation: The company has grown its net assets (financial muscle) from £148,816 in 2015 to £601,509 in 2024. This steady, long-term compounding indicates a business that is building strength organically rather than relying on artificial stimulants (debt).

3. Diagnosis

The patient is in the prime of its financial life. Over its 23-year history, ASSIGN-IT LIMITED has built a fortress balance sheet. The core diagnosis is Financial Hyper-liquidity with Organic Equity Growth.

Looking at the medical charts (financial history), there was a slight dip in net assets from 2022 (£640,446) to 2023 (£575,685). However, this is not a symptom of an underlying illness. Because the P&L reserve dropped by a similar margin while cash remained robust, this represents a healthy extraction of value—likely a dividend payout to the directors/owners—rather than a trading loss. The business recovered its net asset base in 2024, proving its underlying metabolism (profit generation) remains highly active.

The only "condition" to note is a potential case of financial sedentary behavior. Holding over £698,000 in low-yield cash means the company is extremely safe, but it may not be putting its capital to the most productive use. Like a patient resting in bed when they could be running marathons, the cash is sitting idle rather than being deployed for growth or distributed to shareholders.

4. Recommendations

To maintain and optimize this excellent state of financial wellness, the following prescriptions are recommended:

• Active Capital Deployment (Cardiovascular Exercise): With nearly £700k in cash, the business should evaluate whether these funds are needed for near-term working capital. If not, consider increasing dividend distributions to shareholders or investing in higher-yield, short-term financial instruments to improve the return on assets.
• Review Trade Debtors (Immune System Boost): Debtors stand at £157,586. While not alarming, ensuring prompt collection will keep the cash conversion cycle tight and prevent any potential bad-debt infections from setting in.
• Strategic Reinvestment (Growth Hormones): As an IT consultancy, the company's primary asset is its people and expertise. If the directors wish to scale the business further, strategic reinvestment of this cash surplus into talent acquisition, marketing, or proprietary software development could accelerate growth.
• Succession & Contingency Planning (Long-term Health Regime): At 23 years old, the company is mature. Ensure that the heavy reliance on cash reserves is protected by appropriate deposit insurance and that the business is structured to withstand the potential departure of key directors.